ONCOCYTE CORP

CUSIP: 68235C107 Class: COM

CITADEL ADVISORS LLC's Holding History (CIK: 0001423053)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023
Shares 251,952 Value ($000) $58 Avg Close — Range —
Q3 2022
Shares 27,454 Value ($000) $20 Avg Close — Range —
Q2 2022
Shares 251,517 Value ($000) $226 Avg Close — Range —
Q1 2022
Shares 40,860 Value ($000) $61 Avg Close — Range —
Q4 2021
Shares 32,468 Value ($000) $70 Avg Close — Range —
Q3 2021
Shares 34,704 Value ($000) $124 Avg Close — Range —
Q2 2021
Shares 67,745 Value ($000) $388 Avg Close — Range —
Q1 2021
Shares 116,221 Value ($000) $603 Avg Close — Range —
Q4 2020
Shares 55,344 Value ($000) $132 Avg Close — Range —
Q3 2020
Shares 17,427 Value ($000) $24 Avg Close — Range —
Q2 2020
Shares 35,627 Value ($000) $68 Avg Close — Range —
Q1 2020
Shares 22,656 Value ($000) $56 Avg Close — Range —
Q2 2019
Shares 15,145 Value ($000) $38 Avg Close — Range —
Q1 2018
Shares 17,771 Value ($000) $37 Avg Close — Range —